Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.
about
Recent Literature on Medication Errors and Adverse Drug Events in Older AdultsA systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practiceA Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer Patient.Drug prescribing during the last year of life in very old people with diabetes.Anticholinergic Drug Burden in Noncancer Versus Cancer Patients Near the End of Life.Statins Are Associated With Reduced Mortality in Multiple Myeloma.Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by represThe feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.Evidence-based deprescribing of statins in patients with advanced illness.Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.'I don't think I'd be frightened if the statins went': a phenomenological qualitative study exploring medicines use in palliative care patients, carers and healthcare professionals.Organising medication discontinuation: a qualitative study exploring the views of general practitioners toward discontinuing statins.Can cardiovascular disease guidelines that advise treatment decisions based on absolute risk be improved?The Burden of Polypharmacy in Patients Near the End of LifeRenal Insufficiency and Medication in Nursing Home Residents. A Cross-Sectional Study (IMREN).Multimorbidity in Older Patients with Cardiovascular Disease.PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients.General Practitioners' Decision Making about Primary Prevention of Cardiovascular Disease in Older Adults: A Qualitative Study.Patterns of statin initiation and continuation in patients with breast or colorectal cancer, towards end-of-life.Better Together: The Making and Maturation of the Palliative Care Research Cooperative Group.Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study.A Home-Based Palliative Care Consult Service for Veterans.A medication review and deprescribing method for hospitalised older patients receiving multiple medications.High Symptom Burden and Low Functional Status in the Setting of Multimorbidity.The Variation of Statin Use Among Nursing Home Residents and Physicians: A Cross-Sectional Analysis.Should we refrain from antibiotic use in hospice patients?Choosing wisely in case of hypertension, diabetes and hyperlipidemia in older patients.Perceptions of Statin Discontinuation among Patients with Life-Limiting Illness.Medication appropriateness for patients with dementia approaching the end of their life.Discontinuation of Statins: What Are the Risks?Deprescribing: An Application to Medication Management in Older Adults.Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia.Patient-Centred Care of Older Adults With Cardiovascular Disease and Multiple Chronic Conditions.Statin withdrawal in people with dementia.Drug use in persons with and without Alzheimer's disease aged 90 years or more.Statins for Primary Prevention of Cardiovascular Events and Mortality in Older Men.Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial.Symptom Burden and End-of-Life Treatment Preferences in the Very Old.
P2860
Q26775182-4716EB7C-74A0-4B06-985E-1EE3D29CF567Q28078344-D21C4DD2-B8A2-4064-9385-61835DBBBAF4Q30276856-6E4E7FA6-05A3-4FFB-AE15-29BE01FC8A4EQ33553738-39A8B622-4707-48A4-9DF2-F3B380F7E5A3Q33802529-9BDBA38C-8CE5-4495-9C23-2123CD75C7C6Q33816591-1019E6FE-21B0-47D1-A719-3DE77E640B2BQ33845468-A12C6462-A1CF-4566-8F5B-85B921ADADC9Q34046881-2A8F1E4A-084A-4C31-8FF7-345F07EC1107Q34522113-07461293-300E-400F-A26E-9A5CEC14DF85Q35572237-43F80DAB-6FE4-46FC-BD86-6EF5E00E6209Q35894338-01BBBFEA-C59F-4B68-AE8D-0480DE4DB550Q35907831-1B5F43D2-A21A-44DC-9F7E-06AFA3EBDF8CQ36070018-696697FF-0ED4-4471-93EB-20B3386B8160Q36193205-27CCDAA8-4ABE-4B71-90B1-FEE4A2B0C9DCQ36522682-76152691-1B2E-4C88-BE26-A390CEC4A686Q36662176-8F929363-BF2E-4E59-96C9-A270049371DFQ36956600-99505042-71C8-4477-B9D3-CD8A95F784D3Q37549374-CB11D679-8BBE-4FAD-8CAF-5BAFDA44BD9FQ37580870-42F85702-C7FA-4583-B038-C16C939B7E96Q37585702-F8E12183-472D-4CA8-9D30-8D14A3E26202Q37736058-5016DC26-8808-42D3-897D-380327570DD2Q38371107-FA33661D-9C73-496E-9431-A3E63D70B2A1Q38386616-FE6E9C28-E4AA-4ED1-8C75-67F07E992715Q38554879-BB5C6A32-033C-43BF-92EA-D1BDA51887FEQ38589894-0D0CF4D4-3C56-42AD-8E24-94704CEFD17DQ38600686-1ED208A4-A7B2-46E2-A247-C6496D620B95Q38632756-B0B447F1-CCB8-4FD1-AE0F-0552C2F8F786Q38660889-EC6E1044-C8BE-44F9-A24F-FD36F5735B63Q38711884-CB614B5E-330C-44B7-A404-9E3C1DE6B28CQ38777309-67CCF6C3-B373-4AEA-8617-AE3C9BBBACEEQ38823681-E96441B4-C284-4370-B73A-2F4002E09E6AQ38843485-34CCFE65-39E5-4E63-A479-D0ADFA3B754CQ38855300-936FFF4D-F360-4A6E-9DD0-313CE4AA9EC9Q38859941-8B43003E-E5DC-48F5-A0B0-223F86DC4DC7Q38886136-89C5052E-920C-4184-829C-80958E795EE1Q38950072-234E3BAD-3CDD-44B3-A1FF-3398446F908EQ39409144-6F96F047-C0C5-499E-ADDD-B6733C5270E6Q40047849-207D4E9B-A0F2-4597-ACA9-A05F352296E6Q40366138-D108B8D6-1040-4214-976C-1AC378C4AF1FQ40717429-A31A05DE-0A62-4310-A0F2-B10A968C3200
P2860
Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Safety and benefit of disconti ...... : a randomized clinical trial.
@ast
Safety and benefit of disconti ...... : a randomized clinical trial.
@en
type
label
Safety and benefit of disconti ...... : a randomized clinical trial.
@ast
Safety and benefit of disconti ...... : a randomized clinical trial.
@en
prefLabel
Safety and benefit of disconti ...... : a randomized clinical trial.
@ast
Safety and benefit of disconti ...... : a randomized clinical trial.
@en
P2093
P2860
P50
P1476
Safety and benefit of disconti ...... : a randomized clinical trial.
@en
P2093
Adeboye B Ogunseitan
Amy P Abernethy
Arif H Kamal
Betty Ferrell
Charles F Von Gunten
Christine S Ritchie
Cordt Kassner
Diane L Fairclough
Donald H Taylor
Elizabeth A Kvale
P2860
P304
P356
10.1001/JAMAINTERNMED.2015.0289
P577
2015-05-01T00:00:00Z